Skip to main content
logo
Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
3.200
+0.040 (1.27%)
Sep 18, 2026, 4:00 PM EDT - Market closed

Kalaris Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-44.26-43.44-69.17-14.7-15.49
Depreciation & Amortization
0.030.01---
Other Amortization
-0.1938.020.891.99
Asset Writedown & Restructuring Costs
----0.16
Loss (Gain) From Sale of Investments
-0.73-0.4---
Stock-Based Compensation
2.21.940.90.150.27
Other Operating Activities
0.14-0.111.710.62-0.11
Change in Accounts Payable
-2.56-0.09-1.03-0.41.83
Change in Other Net Operating Assets
4.173.52-1.1-0.691.57
Operating Cash Flow
-41.02-38.37-20.67-14.13-9.78
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-0.2-0.2---
Investment in Securities
-49.7-19.52---
Investing Cash Flow
-49.9-19.72---

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Short-Term Debt Issued
-7.519.97--
Long-Term Debt Issued
---64.3
Total Debt Issued
-7.519.9764.3
Net Debt Issued (Repaid)
-7.519.9764.3
Issuance of Common Stock
42.08420-0.01
Other Financing Activities
3.58105.51-2.42--
Financing Cash Flow
45.67155.0119.1414.2412.78

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
-45.2596.91-1.530.113

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-41.22-38.57-20.67-14.13-9.78
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-1.92-2.53-15.47-2.33-2.20
Levered Free Cash Flow
-26.24-23.19-18.82-9.43-
Unlevered Free Cash Flow
-26.24-22.36-31.39-9.34-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Change in Working Capital
1.613.43-2.13-1.093.4
SEC Filings: 10-K · 10-Q